Home  >  Products  >  HSH2D (hematopoietic SH2 domain containing) Blocking Peptide (the C terminal of HSH2D)(100ug)
HSH2D (hematopoietic SH2 domain containing) Blocking Peptide (the C terminal of HSH2D)(100ug)

HSH2D (hematopoietic SH2 domain containing) Blocking Peptide (the C terminal of HSH2D)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-HSH2D Antibody (ARP60697_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP60697
Size: 100ug
Weight: 39kDa
Gene: 84941
Format: Lyophilized powder
Target: T-cell activation requires 2 signals: recognition of antigen by the T-cell receptor and a costimulatory signal provided primarily by CD28 in naive T cells. HSH2 is a target of both of these signaling pathways.
Alternative names: ALX; FLJ14886; HSH2
See Full Product Listings >